CDK6 and cancer: While KSHV deploys vCyclin which hijacks CDK6 to constitutively activate CAD regardless of cell cycle, it is reasonable to propose that non-viral cancer cells (such as BJAB) may have evolved similar mechanisms to exploit CAD for anabolic metabolism and tumorigenesis via dysregulated Cyclin Ds, potentially making CAD an Achilles’ heel for them.